161 related articles for article (PubMed ID: 31333846)
1. Enterohepatic circulation of glucuronide metabolites of drugs in dog.
Zhou X; Cassidy KC; Hudson L; Mohutsky MA; Sawada GA; Hao J
Pharmacol Res Perspect; 2019 Aug; 7(4):e00502. PubMed ID: 31333846
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
Mamidi RN; Cuyckens F; Chen J; Scheers E; Kalamaridis D; Lin R; Silva J; Sha S; Evans DC; Kelley MF; Devineni D; Johnson MD; Lim HK
Drug Metab Dispos; 2014 May; 42(5):903-16. PubMed ID: 24568888
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of Metabolic and Disposition Pathways for Maribavir in Nonhuman Primates through Mass Balance and Semi-Physiologically Based Modeling Approaches.
Sun K; Welty D
Drug Metab Dispos; 2021 Nov; 49(11):1025-1037. PubMed ID: 34462268
[TBL] [Abstract][Full Text] [Related]
4. Enterohepatic circulation of lorazepam and acetaminophen conjugates in ponies.
Greenblatt DJ; Engelking LR
J Pharmacol Exp Ther; 1988 Feb; 244(2):674-9. PubMed ID: 3346841
[TBL] [Abstract][Full Text] [Related]
5. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
6. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of the enterohepatic circulation of acetaminophen glucuronide in rats.
Watari N; Hanawa M; Iwai M; Kaneniwa N
J Pharmacobiodyn; 1984 Nov; 7(11):811-9. PubMed ID: 6530646
[TBL] [Abstract][Full Text] [Related]
8. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Basis of Cabotegravir-Glucuronide Disposition in Humans.
Patel M; Eberl HC; Wolf A; Pierre E; Polli JW; Zamek-Gliszczynski MJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):269-277. PubMed ID: 31175220
[TBL] [Abstract][Full Text] [Related]
10. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
11. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs.
Biehl ML; Prelusky DB; Koritz GD; Hartin KE; Buck WB; Trenholm HL
Toxicol Appl Pharmacol; 1993 Jul; 121(1):152-9. PubMed ID: 8337696
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
Dalvie DK; Khosla NB; Navetta KA; Brighty KE
Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
[TBL] [Abstract][Full Text] [Related]
13. Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence.
Liu H; Sun H; Lu D; Zhang Y; Zhang X; Ma Z; Wu B
Xenobiotica; 2014 Aug; 44(8):696-707. PubMed ID: 24555821
[TBL] [Abstract][Full Text] [Related]
14. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.
Paul H; Illing A; House ES
Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Correlation of Hepatic Fraction of Metabolism by P450 in Dogs.
Zhou X; Hui YH; Hudson L; Katyayan KK; Mohutsky MA; Hao J; Schober DA; Hembre EJ
J Pharm Sci; 2019 Feb; 108(2):1017-1026. PubMed ID: 30244007
[TBL] [Abstract][Full Text] [Related]
16. Application of ultrasound-guided cholecystocentesis to the evaluation of the metabolite profiling in bile of dogs and cynomolgus monkeys.
Dierks EA; Luk CE; Cai H; MacGuire J; Fox M; Smalley J; Fancher RM; Janovitz E; Foster K; Sun Q
Pharmacol Res Perspect; 2019 Jun; 7(3):e00488. PubMed ID: 31149343
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure.
Zamek-Gliszczynski MJ; Abraham TL; Alberts JJ; Kulanthaivel P; Jackson KA; Chow KH; McCann DJ; Hu H; Anderson S; Furr NA; Barbuch RJ; Cassidy KC
Drug Metab Dispos; 2013 Apr; 41(4):714-26. PubMed ID: 23305709
[TBL] [Abstract][Full Text] [Related]
18. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
[TBL] [Abstract][Full Text] [Related]
20. Enterohepatic circulation of clioquinol in the rat.
Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
J Pharmacobiodyn; 1984 Jun; 7(6):420-5. PubMed ID: 6237189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
